The following study had 2 synovial sarcoma patients
The phase 2 trial testing pazopanib/nivolumab combination is not yet recruiting:
The following study had 2 synovial sarcoma patients
The phase 2 trial testing pazopanib/nivolumab combination is not yet recruiting: